RESEARCH ARTICLE 37.Durind A Tho 38.C 6D80e0D011 39. o, 40. 45. 46R 42.Sancer.RESEARCH Article 37. Durinck, S. et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439–3440 (2005). 38. Cerami, E. G. et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 39, D685–D690 (2011). 39. Iorio, F. et al. Pathway-based dissection of the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich. Sci. Rep. 8, 6713 (2018). 40. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013). 41. Cokelaer, T. et al. GDSCTools for mining pharmacogenomic interactions in cancer. Bioinformatics 34, 1226–1228 (2018). 42. Storey, J. D. & Tibshirani, R. Statistical signifcance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003). 43. Mi, H., Muruganujan, A. & Thomas, P. D. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 41, D377–D386 (2013). 44. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014). 45. Garcia-Alonso, L. et al. Transcription factor activities enhance markers of drug sensitivity in cancer. Cancer Res. 78, 769–780 (2018). 46. Ritchie, M. E. et al. limma powers diferential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015). 47. Baralis, E., Bertotti, A., Fiori, A. & Grand, A. LAS: a software platform to support oncological data management. J. Med. Syst. 36, 81–90 (2012)